Harrisons Pulmonary and Critical Care Medicine
Báo cáo y học: "Eighth World Congress of Intensive and Critical Care Medicine, 28 October–1 November 2001, Sydney, Australia: Harm minimization and effective risk managemen" doc
... of pituitary failure in patients who are critically ill for protracted periods intensive care: that of harm minimisation and risk management Microcirculation and oxygen delivery Dr Can Ince of ... Critical Care February 2002 Vol No Ramakrishnan of hyperglycaemia in critically ill patients A total of 1548 medical and surgical patients were randomised on admission ......
Báo cáo y học: "Blending science and compassion: The 30th educational symposium of the Society of Critical Care Medicine, San Francisco, USA, 10–14 February 2001" pptx
... result of the decision to withhold or withdraw care, so there is a need for objective measurements of standard of care The needs of the patient, their family, and those of the nurses and physicians ... unlikely that an investigator can get any patient assessment of the standard of their care The question then is whether the tools used to measure quality o...
Critical care medicine - part 1 ppsx
... Warfarin (Coumadin) Overdose 10 5 10 5 10 6 10 6 10 8 10 9 10 9 11 0 11 1 11 1 11 2 11 2 11 3 11 3 11 4 11 5 Neurologic Disorders ... 12 5 12 5 12 7 13 0 13 3 13 4 13 5 13 6 14 0 14 1 Commonly Used Formulas 14 2 Commonly Used Drug Levels 14 2 Index ... IV push over 1- 3 sec 1- 2 Wide-complex tachycardia of uncertain type Ventricul...
Critical care medicine - part 2 ppsx
... Myoglobin 1-4 h 6-7 h 1 8 -2 4 h CTnl 3-1 2 h 1 0 -2 4 h 3-1 0 d CTnT 3-1 2 h 1 2- 4 8 h 5-1 4 d CKMB 4-1 2 h 1 0 -2 4 h 4 8-7 2 h CKMBiso 2- 6 h 12 h 38 h CTnI, CTnT = troponins of cardiac myofibrils; CPK-MB, MM = ... Interventions 21 -Metoclopramide (Reglan) 1 0 -2 0 mg PO, IM, IV, or in J tube q6h -Famotidine (Pepcid) 20 mg J-tube q12h OR -Ranitidine (Zanta...
Critical care medicine - part 3 docx
... Class Ib -Lidocaine 5 0-1 00 mg (1 mg/kg) IV, then 2-4 mg/min IV -Mexiletine (Mexitil) 10 0-2 00 mg PO q8h, max 1200 mg/d -Tocainide (Tonocard) loading 40 0-6 00 mg PO, then 40 0-6 00 mg PO q 8-1 2h; max ... hypomagnesemia -Defibrillate with 36 0 J -Magnesium sulfate (drug of choice), gm IV push -Isoproterenol (Isuprel) 2-2 0 :g/min (2 mg in 500 mL D5W, :g/mL) OR -Phenytoin (Di...
Critical care medicine - part 4 ppsx
... inhaler (250 :g/puff) 2 -4 puffs bid Fluticasone Flovent metered-dose inhaler (44 , 110 or 220 :g/puff) dry-powder inhaler (50, 100 or 250 :g/inhalation) 2 -4 puffs bid (44 :g/puff) inhalation bid ... 1-2 capsules q 4- 6 h PRN Albuterol Proventil multi-dose vials Ventolin Nebules Ventolin nebulized 2.5 mg q 4- 6 h PRN Levalbuterol - Xopenex nebulized 0.6 3-1 .25 mg q 6-8 h PRN I...
Critical care medicine - part 5 pdf
... 104(2) :50 0 -5 Tobin MJ Mechanical Ventilation NEJM, 1994, 330( 15) : 1 05 6-6 1 Esteban A et al A Comparison of four methods of weaning patients from mechanical ventilation NEJM, 19 95, 332 (6):34 5- 3 50 ... 2 05: 45 3-4 58 Kollef et al The Acute Respiratory Distress syndrome NEJM 19 95, 332(1):2 7-3 7 Amato et al Effect of a protective-ventilation strategy on mortality in the...
Critical care medicine - part 6 pdf
... Cephalosporins Second-generation Third-generation (anti-Pseudomonas aeruginosa) Beta-lactam/beta lactamase inhibitors 1-2 g IV q8h 1-2 g IV q8h 1-2 g IV q8h 3.375 g IV q6h 3.1 g IV q6h D Critically ill ... then 5 0-7 5 mg qd plus leucovorin calcium (folinic acid) 1 0-2 0 mg PO qd for 6- 8 weeks for acute therapy AND B Sulfadiazine (1. 0-1 .5 gm PO q6h) or clindamycin 450 mg PO q...
Critical care medicine - part 7 pdf
... bleeding secondary to protal hypertension AJG 19 97; 92 (7) : 108 1-9 1 Riordan SM; Williams R: Treatment of hepatic encephalopathy NEJM 19 97; 3 37( 7): 47 3 -7 9 Haber PS; Perola EC; Wilson JS: Clinical update: ... continuous infusion at 6.2 5-1 2.5 mg/h [15 0-3 00 mg in 250 mL D5W over 24h (11 cc/h)], or 50 mg IV q 6-8 h OR B Cimetidine (Tagamet) 300 mg IV bolus, then continuous...
Critical care medicine - part 8 docx
... later than 8- 1 2 hours after ingestion Treatment after 1 6-2 4 hours of non-sustained release formulation is significantly less effective, but should still be accomplished D Oral N-acetyl-cysteine ... with sorbitol 50 gm via nasogastric tube q 4-6 h around-the-clock until the serum level decreases to therapeutic range Maintain the head-of-bed at a 3 0-4 5 degree angle to prevent aspir...
Critical care medicine - part 9 doc
... Stroke N Engl J Med 2000; 343:71 0-7 22 Lowenstein DH, et al Status epilepticus N Engl J Med 199 8; 338 :97 0 -9 76 126 Status Epilepticus Diabetic Ketoacidosis 127 Endocrinologic Disorders and Nephrologic ... Two-thirds of the total dose is given in the morning as two-thirds NPH and one-third regular insulin The remaining one-third of the total dose is given before supper as one-half NPH...
Từ khóa:
- overview of anesthesiology and critical care medicine
- pulmonary medicine and critical care
- xử trí tarascon internal medicine and critical care pocketbook
- ethical and legal aspects of critical care medicine
- ptx3 possible role in critical care medicine
- a new conceptual framework in critical care medicine
- postoperative and critical care in the elderly cardiac surgery patient
- postoperative and critical care in the elderly thoracic surgery patient